Fornasier, Marco, et al. Journal of Colloid and Interface Science 677 (2025): 842-852.
Span 80 (Sorbitan monooleate), a nonionic surfactant, plays a crucial role in stabilizing monoolein-based cubosomes and hexosomes for photodynamic therapy (PDT) in skin metastatic melanoma treatment. In this study, Span 80 was employed in combination with sodium taurocholate (TC) to formulate bicontinuous cubic or hexagonal nanoparticles. These nanoparticles were optimized through small-angle X-ray scattering and cryo-transmission electron microscopy, which confirmed their structure depending on the ratio of TC to Span 80.
The addition of Span 80, in conjunction with taurocholate, enhanced the stability and biocompatibility of the nanoparticles, facilitating efficient dermal and transdermal drug delivery. This was particularly important in overcoming the skin's stratum corneum barrier. The nanoparticles were co-loaded with Chlorin e6 (Ce6), a photosensitizer, and coenzyme QH (CoQH), an antioxidant, both of which demonstrated high encapsulation efficiency. In vitro studies on human melanoma cells (Me45) showed that the co-loaded formulations exhibited notable photodynamic activity, paving the way for their potential use in skin cancer treatments.
These findings highlight the essential role of Span 80 in the formulation of non-lamellar lipid nanoparticles, providing an effective platform for PDT in skin cancer therapy with enhanced biocompatibility and drug encapsulation.